Gibson CM, Bahit MC, Mehran R, Mehta SR, et al. Oral Factor XIa Inhibitor Milvexian After a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (Librexia ACS). Am Heart J 2025 Feb 20:S0002-8703(25)00044-4. doi: 10.1016/j.ahj.2025.
PMID: 39986336